

"AI-designed nutraceutical formulations powered by microbiome science"
Enbiosis develops scientifically backed nutraceutical formulations using artificial intelligence and microbiome modeling. The company creates digital twins of the human gut microbiome to identify food-grade molecules that drive specific biological responses, then engineers these into scalable powder premixes for supplement manufacturers and health brands. Operating as a B2B formulation partner, Enbiosis supplies ready-to-manufacture nutraceutical blends for capsules, sachets and functional foods. The approach targets the microbiome to guide biological pathways, delivering clinically proven outcomes across digestive health, cognitive function, metabolic conditions and mental wellbeing for patients and practitioners.


21
Team Members
2019
Founded
Biotechnology
Sector
Hybrid
Work Environment
A world where human lifespan nearly doubles, accompanied by prolonged healthspan and sustained youthful vitality through microbiome-based precision nutrition.
Enbiosis advances microbiome science and develops precision health technologies that enable personalized nutrition to transform human health and longevity.